Amylyx Pharmaceuticals Investor Lawsuit: Overstated Drug Potential?
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
- Latest
- Trending
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
Ohio-based manufacturing sector stocks saw positive price changes last week, with several companies leading the way. Stocks of Parker-Hannifin Corp., ...
Vertex Pharmaceuticals is capturing the attention of investors with its expansion into pain management and cell/gene therapies. With positive earnings ...
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
Biotechnology company Invizyne Technologies plans to raise $15.5 million through an initial public offering of 4.3 million shares at $4 ...
Investing in healthcare stocks can be a lucrative venture as the medical industry continues to thrive. The sector offers various ...
Discover Warren Buffett's early success as a hedge fund manager and his strategy for generating high returns, offering valuable lessons ...
Get ready for an unforgettable experience of technology, entertainment, and inspiration at Teknofest 2024 in Adana, Türkiye's largest space, aviation, ...
HutanBio secures GBP 2.25 million from UK's Clean Growth Fund for biofuel development and global expansion. #biotechnology #cleanenergy #investment
Will the stock market's winning streak continue in 2024? Find out what the charts and experts are saying about the ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.